Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis

Citation
A. Turlakow et al., Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis, ARCH IN MED, 161(7), 2001, pp. 1003-1007
Citations number
25
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
ARCHIVES OF INTERNAL MEDICINE
ISSN journal
00039926 → ACNP
Volume
161
Issue
7
Year of publication
2001
Pages
1003 - 1007
Database
ISI
SICI code
0003-9926(20010409)161:7<1003:FPETIT>2.0.ZU;2-W
Abstract
We describe a case in which fludeoxyglucose F18 positron emission tomograph y (PET) led directly to the diagnosis of giant cell arteritis in an elderly woman with a fever of unknown origin. The patient presented with a 3-month history of fatigue, fever, headache, visual disturbance, jaw claudication, and anemia. A computed tomographic scan showed an anterior mediastinal mas s that was suspected of being malignant. A fludeoxyglucose F 18 PET scan pe rformed for preoperative evaluation identified striking uptake of fludeoxyg lucose F 18 in the walls of the entire aorta, left main coronary artery, an d sub-clavian, carotid, and common iliac arteries bilaterally, suggestive o f an arteritis, a diagnosis subsequently confirmed by the findings of an ar terial biopsy. Her erythrocyte sedimentation rate was 129 mm/h. There was n ormalizaton of the PET scan 2 weeks following treatment with prednisolone. This case suggests that fludeoxyglucose F 18 PET contributes to the noninva sive diagnosis of giant cell arteritis, as well as to the evaluation of the extent of disease, response to therapy, and disease recurrence.